As of 2024-12-14, the Relative Valuation of Nuvation Bio Inc (NUVB) is (42.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.61 USD, the upside of Nuvation Bio Inc based on Relative Valuation is -1725.4%.
The range of the Relative Valuation is (39.38) - (46.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.0x - 29.2x | 26.6x |
| Forward P/E multiples | 24.9x - 29.2x | 27.0x |
| Fair Price | (39.38) - (46.18) | (42.42) |
| Upside | -1608.8% - -1869.3% | -1725.4% |
| Date | P/E |
| 2024-12-12 | -1.66 |
| 2024-12-11 | -1.69 |
| 2024-12-10 | -1.71 |
| 2024-12-09 | -1.77 |
| 2024-12-06 | -1.80 |
| 2024-12-05 | -1.75 |
| 2024-12-04 | -1.74 |
| 2024-12-03 | -1.83 |
| 2024-12-02 | -1.88 |
| 2024-11-29 | -1.83 |
| 2024-11-27 | -1.83 |
| 2024-11-26 | -1.83 |
| 2024-11-25 | -1.83 |
| 2024-11-22 | -1.77 |
| 2024-11-21 | -1.71 |
| 2024-11-20 | -1.63 |
| 2024-11-19 | -1.64 |
| 2024-11-18 | -1.62 |
| 2024-11-15 | -1.66 |
| 2024-11-14 | -1.81 |
| 2024-11-13 | -1.87 |
| 2024-11-12 | -1.85 |
| 2024-11-11 | -1.90 |
| 2024-11-08 | -1.82 |
| 2024-11-07 | -1.66 |
| 2024-11-06 | -1.61 |
| 2024-11-05 | -1.47 |
| 2024-11-04 | -1.45 |
| 2024-11-01 | -1.45 |
| 2024-10-31 | -1.40 |
| 2024-10-30 | -1.48 |
| 2024-10-29 | -1.49 |
| 2024-10-28 | -1.49 |
| 2024-10-25 | -1.40 |
| 2024-10-24 | -1.45 |
| 2024-10-23 | -1.47 |
| 2024-10-22 | -1.52 |
| 2024-10-21 | -1.49 |
| 2024-10-18 | -1.57 |
| 2024-10-17 | -1.54 |
| 2024-10-16 | -1.63 |
| 2024-10-15 | -1.47 |
| 2024-10-14 | -1.45 |
| 2024-10-11 | -1.44 |
| 2024-10-10 | -1.27 |
| 2024-10-09 | -1.40 |
| 2024-10-08 | -1.41 |
| 2024-10-07 | -1.37 |
| 2024-10-04 | -1.52 |
| 2024-10-03 | -1.48 |